Ropivacaine: a pharmacological review

References

• Tucker GT. Pharmacokinetics of local anaesthetics. Br. Anaesth. 58, 717–731 (1986).
   PubMed Web of Science ®Google Scholar
• Whiteside JB, Wildsmith JAW Developments in local anaesthetic drugs. Br. Anaesth. 87, 27–35 (2001).
   PubMed Web of Science ®Google Scholar
• McClure JH. Ropivacaine. BE j Anaesth. 76, 300–307 (1996).
   PubMed Web of Science ®Google Scholar
• McClellan KJ, Faulds D. Ropivacaine. An update of its use in regional anaesthesia. Drugs 60, 1065–1093 (2000).
   Google Scholar
• Wang RD. Dangler LA, Greengrass RA. Update on ropivacaine. Expert Opin.Pharmacother. 2, 2051–2063 (2001).
   PubMedGoogle Scholar
• Owen MD, Dean LS. Ropivacaine. Expert Opin. Pharmacother. 1, 325–336 (2000).
   PubMedGoogle Scholar
• Albright GA. Cardiac arrest following regional anesthesia with ethidocaine or bupivacaine. 4nesthesiology51, 285–287 (1979).
   Google Scholar
• Knudsen K, Beckman Suurkula M, Blomberg S, Sjöval J, Edvardsson N. Central nervous and cardiovascular effects of iv. infusions of ropivacaine, bupivacaine and placebo in volunteers. BE j Anaesth. 78, 507–514 (1997).
   Google Scholar
• Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth. Analg: 69, 563–569 (1989).
   PubMed Web of Science ®Google Scholar
• Arlock P Actions of three local anaesthetics: lidocaine, bupivacaine and ropivacaine on guinea-pig papillary muscle sodium channels (Vmax). Pharmacol Toxical 63, 96–104 (1988).
   PubMedGoogle Scholar
• Moller R. Covino BG. Cardiac electrophysiologic properties of bupivacaine and lidocaine compared with those of ropivacaine, a new amide local anesthetic. Anesthesiology72, 322–329 (1990).
   Google Scholar
• Reiz S, Häggmark S, Johansson G, Nath S. Cardiotoxicity of ropivacaine a new amide local anaesthetic agent. Acta Anesthesial. Scand. 33, 93–98 (1989).
   PubMed Web of Science ®Google Scholar
• Nancarrow C, Rutten AJ, Runciman WB etal. Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine and ropivacaine in the sheep. Anesth. Analg: 69, 276–283 (1989).
   Google Scholar
• Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine and lidocaine in conscious dogs. Anesth. Analg: 69, 794–801 (1989).
   Google Scholar
• Feldman HS, Arthur GR, Covino BG. Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. Anesth. Analg: 73, 373–384 (1991).
   Google Scholar
• Owen MD, D'Angelo R, Geranscher JC etal 0.125% ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusion. Anesth. Analg: 86, 527–531 (1998).
   Google Scholar
• Zaric D, Nydahl PA, Philipson L, Samuelsson L, Heierson A, Axelsson K. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers. A double-blind study. Reg. Anaesth. 21, 14–25 (1996).
   Google Scholar
• Irestedt L, Ekblom A, Olofsson C, Dahlstrom AC, Emanuelsson BM. Pharmacokinetics and clinical effect during continuous epidural infusion with ropivacaine 2.5 mg/ml or bupivacaine 2.5 mg/m1 for labour pain relief. Acta. Anaesthesial. Scand. 42, 890–896 (1998).
   Google Scholar
• Ivani G, Lampugnani E, De Negri P, Lonnqvist PA, Broadman L. Ropivacaine vs. bupivacaine for major surgery in infants. Can. Anaesth. 46, 467–469 (1999).
   Google Scholar
• Campbell DC, Zwack, RM, Crone LAL, Yip R. Ambulatory labor epidural analgesia: bupivacaine versus ropivacaine. Anesth. Analg: 90, 1384–1389 (2000).
   Google Scholar
• Erichsen CJ, Vibits H, Dahl JB, Kehlet H. Wound infiltration with ropivacaine and bupivacaine for pain relief after inguinal hemiotomy. Acta. Anaesthesia'. Scancl 39, 67–70 (1995).
   PubMed Web of Science ®Google Scholar
• Erichsen CJ, Sjovall J, Kehlet H, Hedlund C, Arvidsson T Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief. Anesthesiology (1996) 84, 834-842 (1995).
   Google Scholar
• Owen MD, D'Angelo R, Gerencher JC et al0.125% ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusion. Anesth. Analg. 86, 527–531 (1998).
   Google Scholar
• Brodner G, Mertes N, van Aken H, Mollhoff T, Zahl M, Wirtz S, Marcus MA, Buerlde H. Epidural analgesia with local anesthetics after abdominal surgery: earlier motor recovery with 0.2% ropivacaine than 0.175% bupivacaine. Anesth. Analg: 88, 128–133 (1999).
   Google Scholar
• Bertini L, Tagariello V, Mancini S et al 0.75% and 0.5% ropivacaine for axillary plexus block: a clinical comparision with 0.5% bupivacaine. Reg. Anesth. Pain Med. 24, 514–518 (1999).
   Google Scholar
• Malinovsky JM, Charles F, Kick 0 et al Intrathecal anesthesia: ropivacaine versus bupivacaine. Anesth. Analg: 91, 1457–1460 (2000).
   Google Scholar
• Brockway MS, Bannister J, McClure JH, McKeown D, Wildsmith JAW Comparison of extradural ropivacaine and bupivacaine. Br. Anaesth. 66, 31–37 (1991).
   PubMed Web of Science ®Google Scholar
• Brown DL, Carpenter RL, Thomson GE. Comparison of 0.5% ropivacaine and 0.5% bupivacaine in patient undergoing lower-extremety surgery. Anesthesiology 72, 633–636 (1990).
   Google Scholar
• Morrison LMM, Emanuelson BM, McClure JH eta]. Efficacy and kinetics of extradural ropivacaine: Comparison with bupivacaine. Br. Anaesth. 72, 269–273 (1994).
   Google Scholar
• Wolff AP, Hasselstrom L, Kerldcamp HE, Gielen MJ. Extradural ropivacaine and bupivacaine in hip surgery. BE j Anaesth. 74, 458–460 (1995).
   PubMed Web of Science ®Google Scholar
• Datta S, Camann W, Bader A, Vanderburgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for caesarian section. Anesthesiology82, 1346–1352 (1995).
   PubMed Web of Science ®Google Scholar
• Panni M, Segal S. New local anesthetics. Are they worth the cost? Anesthesia" Clin. North. A117. 21, 19–38 (2003).
   Google Scholar
• Akerman B, Hellberg TB, Trossvik C. Primary evaluation of the local anesthetic properties of the amino amide agant ropivacaine (LEA 103). Acta. Anaesthesia'. Scancl 32, 571–578 (1998).
   Google Scholar
• Gherardini G, Samuelson U, Jembeck J, Aberg B, Sjostrand N. Comparison of vascular effects of ropivacaine and lidocaine on isolated rings of human arteries. Acta. Anaesthesia'. Scancl 39, 765–768 (1988).
   Google Scholar
• Cederholm I, Evers H, Lofstrom JB. Skin blood flow after intradermal injection of ropivacaine in various concentrations with or without epinephrine evaluated by laser Doppler flowmetry. Reg. Anesth. 17, 322–328 (1992).
   Google Scholar
• Ala-Kokko TI, Partanen A, Karinen J, Kiviluoma K, Alahuhta S. Pharmacokinetics of 0.2% ropivacaine and 0.2% bupivacaine following caudal blocks in children. Acta. Anaesthesia" Scam/. 44, 1099–1102 (2000).
   Google Scholar
• Luz G, Innerhofer P, Häussler B, Oswald E, Salner E, Sparr H. Comparison of ropivacaine 0.1% and 0.2% with bupivacaine 0.2% for single-shot caudal anaesthesia in children. Paecliatc Anaesth. 10, 499–504 (2000).
   Google Scholar
• Karmakar MK, Aun CST, Wong ELY, Wong ASY, Chan SKC, Yeung CK. Ropivacaine undergoes slower systemic absorption from the caudal epidural space in children than bupivacaine. Anesth. Analg: 94, 259–265 (2002).
   PubMed Web of Science ®Google Scholar
• Van Obbergh LJ, Roelants FA, Veyckemans F, Verbeeck RK. In children, the addition of epinephrine modifies the pharmacokinetics of ropivacaine injected caudally. Can. Anaesth. 50, 593–598 (2003).
   PubMed Web of Science ®Google Scholar
• Lee BB, Ngan Kee WD, Plummer JL, Karmakar MK, Wong AS. The effect of the addition epinephrine on early systemic absorption of epidural ropivacaine in humans. Anesth. Analg: 95, 1402–1407 (2002).
   PubMed Web of Science ®Google Scholar
• Alahuhta S, Rasanen J, Jouppila P, Kangas- Saarela T, Jouppila R, Westerling P, Hollmen A. The effects of epidural ropivacaine and bupivacaine for cesarean section on uteroplacental fetal circulation. Anesthesiology83, 23–32 (1995).
   Google Scholar
• Lee A, Fagan D, Lamont M, Tucker GT, Halldin M, Scott DB. Disposition kinetics of ropivacaine in humans. Anesth. Analg. 69, 736–738 (1989).
   PubMed Web of Science ®Google Scholar
• Arthur GR, Feldman HS, Covino BG. Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anaesthetic. Anesth. Analg: 67, 1053–1058 (1988).
   Google Scholar
• Clarkson CW, Hondeghem LM. Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology62, 396–405 (1985).
   PubMed Web of Science ®Google Scholar
• Butterworth JF 4th, Brownlow RC, Leith JP, Prielipp RC, Cole LR. Bupivacaine inhibits cyclic 3-, 5 --adenosine monophosphate production. A possible contributing factor to cardiovascular toxicity. Anesthesiology79, 88–95 (1993).
   Google Scholar
• Santos AC, Arthur GR, Wlody D, De Armas P, Morishima HO, Finster M. Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant ewes. Anesthesiology82, 734–740 (1995).
   Google Scholar
• Lefrant JY, de la Coussaye JE, Ripart J et al The comparative electrophysiologic and hemodynamic effects of a large dose of ropivacaine and bupivacaine in anesthesized and ventilated piglets. Anesth. Analg: 93, 1598–1605 (2001).
   PubMed Web of Science ®Google Scholar
• Emanuelsson BMK, Persson J, Alm C, Heller A, Gustafsson LL. Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers. Anesthesiology 87, 1309–1317 (1997).
   Google Scholar
• Korman B, Riley RII. Convulsions induced by ropivacaine during interscalene brachial plexus block. Anesth. Analg: 85, 1128–1129 (1997).
   PubMed Web of Science ®Google Scholar
• Plowman AN, Bolsin S. Mather LE. Central nervous system toxicity attributable to epidural ropivacaine. Anaesthesia Intensive Care 26, 204–206 (1998).
   PubMed Web of Science ®Google Scholar
• Abouleish EL Elias M, Nelson C. Ropivacaine-induced seizure after extradural anaestheisa. BE j Anaesth. 80, 843–844 (1998).
   PubMed Web of Science ®Google Scholar
• Ruetsch YA, Fattinger KE, Borgeat A. Ropivacaine induced convulsions and severe cardiac dysrhythmia after sciatic block. Anesthesiology90, 1784–1786 (1999).
   Google Scholar
• Cha7alon P, Tourtier JP, Giraud D, Saissy JM, Mion G, Benhamou D. Ropivacaine-induced cardiac arrest after peripheral nerve block: successful resuscitation. Anesthesiology99, 1449–1451 (2003).
   Google Scholar
• Huet 0, Eyrolle LJ, Mazoit JX, Ozier YM. Cardiac arrest and plasma concentrations after injection of ropivacaine for posterior lumbar plexus blockade. Anesthesiology 99, 1451–1453 (2003).
   Google Scholar
• Polley LS, Columb MO, Naughton NN, Wagner DS, Cosmas JM. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labour. Anesthesiology90, 944–950 (1999).
   Google Scholar
• D'Angelo R, James RL. Is ropivacaine less potent than bupivacaine? Anesthesiology92, 283–284 (2000).
   PubMed Web of Science ®Google Scholar
• Capogna G, Celleno D, Fusco P, Lyons G, Columb M. Relative potencies of bupivacaine and ropivacaine for analgesia in labour. Br. Anaesth. 82, 371–373 (1999).
   Google Scholar
• Lee BB, Ngan Kee PD, Wong EL, Liu JYW. Dose-response study of epidural ropivacaine for labor analgesia. Anesthesiology94, 767–772 (2001).
   PubMed Web of Science ®Google Scholar
• Betini L, Benedetto PG. Equipotency of ropivacaine and bupivacaine in peripheral nerve block. Reg. Anesth. Pain Merl 25, 659–660 (2000).
   PubMed Web of Science ®Google Scholar
• Casati A, Fanelli G, Magistris L, Beccaria P, Berti M, Torn i G. Minimum local anesthetic volume blocking femoral nerve in 50% cases: a double-blinded comparison between 0.5% ropivacaine and 0.5% bupivacaine. Anesth. Analg. 92, 205–208 (2001).
   Google Scholar
• Deng XM, Xiao WJ, Tang GZ, Luo MP, Xu KL. The minimum local anesthetic concentration of ropivacaine for caudal analgesia in children. Anesth. Analg. 94, 1465–1468 (2002).
   Google Scholar
• Benhamou D, Ghosh C, Mercier FJ. A randomized sequential allocation study to determine the minimum effective analgesic concentration of levobupivacaine and ropivacaine in patients receiving epidural analgesia for labor. Anesthesiology 99, 1383–1386 (2003).
   Google Scholar
• Polley LS, Columb MO, Naughton NN, Wagner DS, van der Ven CJM, Goralski KH. Relative analgesic potencies of levobupivacaine and ropivacaine for epidural analgesia in labor. Anesthesiology 99, 1354–1358 (2003).
   Google Scholar
• Bjornestad E, Smedvig JP, Bjerkreim T, Narverud G, Kolleros D, Bergheim R. Epidural ropivacaine 7.5 mg/ml for elective caesarean section: a double-blind comparison of efficacy and tolerability with bupivacaine 5 mg/ml. Acta. Anaesthesia" Scam:" 43, 603–608 (1999).
   Google Scholar
• Stienstra R, Jonker TA, Bourdrez P, Kuijpers JC, van Kleef JVV, Lundberg U. Ropivacaine 0.25% versus bupivacaine 0.25% for continuous epidural analgesia in labor: a double-blind comparison. Anesth. Analg. 80, 285–289 (1995).
   Google Scholar
• Gaiser RR, Venkateswaren P, Cheek TG eta]. Comparison of 0.25% ropivacaine and bupivacaine for epidural analgesia for labor and vaginal delivery. J. Gun. Anesth. 9, 564–568 (1997).
   Google Scholar
• Crosby E, Sandler A, Finucane B etal. Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarean section. Can. J. Anaesth. 45, 1066–1071 (1998).
   Google Scholar
• Writer WD, Stienstra R, Eddleston JM et al. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. BE j Anaesth. 81, 713–717 (1998).
   PubMed Web of Science ®Google Scholar
• Halpern SH, Littleford JA, Brockhurst NJ, Youngs PJ, Malike N, Owen HC. The neurologic and adaptive capacity score is not a reliable method of newborn evaluation. Anesthesiology 94, 958–962 (2001).
   PubMed Web of Science ®Google Scholar
• Halpern SH, Walsh V. Epidural ropivacaine versus bupivacaine for labor: a meta-analysis. Anesth. Analg. 96, 1473–1479 (2003).
   PubMed Web of Science ®Google Scholar
• Wulf H, Peters C, Behnke H. The pharmacokinetics of caudal ropivacaine 0.2% in children. A study of infants aged less than 1 year and toddlers aged 1–5 years undergoing inguinal hernia repair. Anaesthesia 55, 757–760 (2000).
   Google Scholar
• McCann ME, Sethna NF, Mazoit JX eta]. The pharmacokinetics of epidural ropivacaine in infants and young children. Anesth. Anal& 93, 893–897 (2001).
   Google Scholar
• Hansen TG, Ilett KF, Reid C, Lim SI, Hackett LP, Bergesio R. Caudal ropivacaine in infants. Population pharmacokinetics and plasma concentrations. Anesthesiology 94, 579–584 (2001).
   Google Scholar
• Hansen TG, Ilett KF, Lim SI, Reid C, Hackett LP, Bergesio R. Pharmacokinetics and clinical efficacy of long-term epidural ropivacaine infusion in children. BE J. Anaesth. 85, 347–353 (2000).
   PubMed Web of Science ®Google Scholar
• Koinig H, Krenn C, Glaser C eta]. The dose-response of caudal ropivacaine in children. Anesthesiology 90, 1339–1344 (1999).
   Google Scholar
• Ivani G. Ropivacaine: is it time for children? Paecliatc Anaesth. 12, 383–387 (2002).
   Google Scholar
• Shulman M, Lubenow TR, Nath HA, Blazek W, McCarthy RJ, Ivankovich AD. Nerve blocks with 5% butamben suspension in the treatment of chronic pain syndromes. Reg. Anesth. Pain Med. 23, 395–401 (1998).
   Google Scholar
• Korsten HH, Ackerman EVV, Grouts RJ etal. Long-lasting epidural sensory blockade by Nbutyl P-aminobenzoate in the terminally ill cancer patient. Anesthesiology75, 950–960 (1991).
   Google Scholar
• Grant GJ, Piskoun B, Bansinath M. Analgesic duration on kinetics of liposomal bupivacaine after subcutaneous injection in mice. Clin. Exp. Phatmacol Physiol. 30, 966–968 (2003).
   Google Scholar
• www.anaesthesia-az.com/homepage/ Naropin/Naropin/ GlobalPrecInformation.asp (Accessed August 2004)
   Google Scholar
• www.anaesthesia-az.com/homepage (Accessed August 2004)
   Google Scholar
• www.medicinpriser.dk (Accessed August 2004)
   Google Scholar